427 related articles for article (PubMed ID: 19231088)
1. Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action.
Tan RS; Scally MC
Med Hypotheses; 2009 Jun; 72(6):723-8. PubMed ID: 19231088
[TBL] [Abstract][Full Text] [Related]
2. Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD; Lipshultz LI; Crosnoe LE; Kovac JR; Kim ED
Fertil Steril; 2014 May; 101(5):1271-9. PubMed ID: 24636400
[TBL] [Abstract][Full Text] [Related]
3. Anabolic steroid induced hypogonadism in young men.
Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
[TBL] [Abstract][Full Text] [Related]
4. Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.
Karavolos S; Reynolds M; Panagiotopoulou N; McEleny K; Scally M; Quinton R
Clin Endocrinol (Oxf); 2015 May; 82(5):624-32. PubMed ID: 25333666
[TBL] [Abstract][Full Text] [Related]
5. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure.
Fragkaki AG; Angelis YS; Koupparis M; Tsantili-Kakoulidou A; Kokotos G; Georgakopoulos C
Steroids; 2009 Feb; 74(2):172-97. PubMed ID: 19028512
[TBL] [Abstract][Full Text] [Related]
6. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
7. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
8. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
9. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
Yesalis CE
AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
[TBL] [Abstract][Full Text] [Related]
10. [Endocrine effects of doping with androgenic anabolic steroids].
Birkeland KI; Jørgensen J; Hemmersbach P
Tidsskr Nor Laegeforen; 1994 Feb; 114(4):426-8. PubMed ID: 8009475
[TBL] [Abstract][Full Text] [Related]
11. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
12. Anabolic steroids and male infertility: a comprehensive review.
de Souza GL; Hallak J
BJU Int; 2011 Dec; 108(11):1860-5. PubMed ID: 21682835
[TBL] [Abstract][Full Text] [Related]
13. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.
Karila T; Hovatta O; Seppälä T
Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244
[TBL] [Abstract][Full Text] [Related]
14. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
15. Anabolic steroid-associated hypogonadism in male hemodialysis patients.
Maeda Y; Nakanishi T; Ozawa K; Kijima Y; Nakayama I; Shoji T; Sasaoka T
Clin Nephrol; 1989 Oct; 32(4):198-201. PubMed ID: 2805460
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
17. Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study.
van Breda E; Keizer HA; Kuipers H; Wolffenbuttel BH
Int J Sports Med; 2003 Apr; 24(3):195-6. PubMed ID: 12740738
[TBL] [Abstract][Full Text] [Related]
18. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
Dunn M; Mazanov J; Sitharthan G
Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
[TBL] [Abstract][Full Text] [Related]
19. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
Abrams D
AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
[TBL] [Abstract][Full Text] [Related]
20. Anabolic androgenic steroids: a survey of 500 users.
Parkinson AB; Evans NA
Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
